Conor Leen (Corofin) 5. Cian Galvin (Clarecastle), 6. John Conlon (Clonlara), 7. David McInerney (Tulla) 8. Seán Rynne (Inagh-Kilnamona) 9. Cathal Malone (Sixmilebridge) In the Leinster SHC ...

Who Is Cian O’Clery? Cian is an Emmy-award winning TV producer who hails from Australia. He cocreated Love on the Spectrum's original Australian version before making an American version of the ...

Mr. McInerney brings over 30 years of industry experience spanning senior executive, finance and capital advisory roles in the pharmaceutical and biotechnology sectors LONDON, May 06, 2025 ...

The lawsuit was filed on behalf of investors who acquired Ibotta securities in connection with Ibotta’s April 18, 2024 initial public offering (“IPO”). Investors have until June 16, 2025, to ...

McInerney, who will be a senior at Bishop Heelan High School in the fall, achieved such status by placing sixth in the Emerging Elite Division at the Nike Outdoor Nationals and USA Track & Field ...

The lawsuit was filed on behalf of investors who acquired Compass securities from May 1, 2024, through May 7, 2025 (“the Class Period”). Investors have until July 8, 2025, to apply to the ...

Always delighted to have Visa. And someone that I respect and admire a lot is here with us, Ryan McInerney. I was looking back, Ryan. I was thinking you joined Visa, what, 2013? But, of course ...

At the end of countless predicted Lions squads over the last couple of years, Andy Farrell’s 38-man group was largely along expected lines, which meant the usual outrage didn’t materialise ...

Pictured at Croke Park in Dublin are, from left, Sligo footballer Pat Spillane Jnr, Allianz first 'Stop the Drop' reporter, nine year old Sheamie Garrihy from Clare and Meath footballer Cian McBride.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired ...

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against CVS Health Corporation (“CVS” or the “Company”) (NYSE:CVS).